Skip to content

Eficacy and safety of Continuous and Micropulse Cyclophotocoagulation on the treatment of refractory Glaucoma

Eficacy and safety of Continuous and Micropulse Transscleral Cyclophotocoagulation on the treatment of refractory Glaucoma. A randomised clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-1049dx8g
Enrollment
Unknown
Registered
2023-12-22
Start date
2024-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

This is a randomized clinical trial. A total of 50 patients with refractory glaucoma who meet the eligibility criteria will be randomly divided into 2 groups: transscleral cyclophotocoagulation with c

Sponsors

Universidade Federal de São Paulo
Collaborator
Universidade Federal de São Paulo
Lead Sponsor

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Visual acuity better than or equal to light perception; diagnosis of refractory glaucoma, by the attending physician: uncontrolled intraocular pressure, presence of previous fistulizing glaucoma surgery and/or glaucoma drainage implant, contraindication to fistulizing surgery and glaucoma drainage implant; indication of cyclophotocoagulation by the attending physician

Exclusion criteria

Exclusion criteria: Under 18 years old; previous cyclophotocoagulation procedure; presence of retinal and/or choroidal detachment; presence of perilimbic scleral thinning or any other anatomical change that prevents transscleral cyclophotocoagulation; presence of an eye tumor; patients unable to perform the proposed exams or remain in the study for any reason

Design outcomes

Primary

MeasureTime frame
Assess the reduction in intraocular pressure measured with a Goldmann applanation tonometer or a portable tonometer, which should be similar between groups

Secondary

MeasureTime frame
Pain control referred subjectively by the patient should be similar or better in the study group;The change in corrected visual acuity measured with an optotype projector should be similar between groups or better in the study group

Countries

Brazil

Contacts

Public ContactDiogo Landim

Universidade Federal de São Paulo

diogo.landim@hotmail.com+55(11)5576-4000

Outcome results

None listed

Source: REBEC (via WHO ICTRP)